The Journal of the American Dental Association
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Dent Assoc, Vol 138, No 10, 1309-1310.
© 2007 American Dental Association

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content

NEWS

RESEARCHERS IDENTIFY TASTE RECEPTORS IN HUMAN INTESTINES

Researchers at Mount Sinai School of Medicine, New York City, have identified taste receptors in the human intestines, according to a study published online Aug. 27 in the Proceedings of the National Academy of Sciences.

The taste receptor T1R3 and the taste G protein gustducin are critical to sweet taste in the tongue. The study findings show that these two sweet-sensing proteins also are expressed in specialized taste cells of the gut, where they sense glucose within the intestine.

"We now know that the receptors that sense sugar and artificial sweeteners are not limited to the tongue," said Robert F. Margolskee, MD, PhD, professor of neuroscience and the lead author.

‘"Our work is an important advance for the new field of gastrointestinal chemosensation—how the cells of the gut detect and respond to sugars and other nutrients," Dr. Margolskee said.

"Cells of the gut taste glucose through the same mechanisms used by taste cells of the tongue," said Dr. Margolskee. "The gut taste cells regulate secretion of insulin and hormones that regulate appetite."

Carbohydrate ingested from food and beverages breaks down into glucose, which stimulates the sweet-sensing proteins in these gut taste cells. Activating the sweet-sensing proteins of the gut taste cells promotes secretion of glucagonlike peptide-1, an intestinal hormone that plays a key role in promoting insulin secretion and regulating appetite.

The study findings may lead to new treatments for obesity and diabetes.

Dr. Margolskee has a financial interest in Redpoint Bio, Ewing, N.J., a biotechnology firm that identifies and develops compounds to improve the taste of pharmaceutical, food and beverage products. A coauthor is the inventor of the intestinal glucose sensor, which is protected by a patent.

This research was supported by funding from the National Institute on Deafness and Other Communication Disorders, National Institutes of Health.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS